Literature DB >> 11114288

Dephosphorylation of autoantigenic ribosomal P proteins during Fas-L induced apoptosis: a possible trigger for the development of the autoimmune response in patients with systemic lupus erythematosus.

S Zampieri1, W Degen, A Ghiradello, A Doria, W J van Venrooij.   

Abstract

OBJECTIVES: Autoimmune diseases are characterised by the production of autoantibodies against various autoantigens. In the past few years data have been published on a possible role of apoptosis in the development of autoimmunity. These include the finding that several autoantigens become modified (for example, by cleavage) during apoptosis, and the observation that these modified antigens are translocated to the cell surface. When the normal clearance of apoptotic cells somehow is disturbed, such modified antigens might become exposed to the immune system. Because acidic ribosomal P (phospho-) proteins targeted by autoantibodies in systemic lupus erythematosus (SLE) are also concentrated at the surface of apoptotic cells, this study aimed at investigating what modifications occur on these antigens during apoptosis.
METHODS: Apoptosis in Jurkat cells was induced by Fas ligand (Fas-L), and the fate of autoantigenic P proteins was analysed in both normal and apoptotic total cell extracts.
RESULTS: The autoantigenic P proteins were not cleaved but dephosphorylated during Fas-L induced apoptosis. This dephosphorylation was prevented when caspase activity was inhibited.
CONCLUSIONS: As has been shown for other autoantigens targeted by autoantibodies in SLE, P proteins also are modified during apoptosis. P1 and P2 are completely dephosphorylated while P0 is partly dephosphorylated. Because the epitope targeted by autoantibodies normally is phosphorylated, it is possible that the apoptotic dephosphorylation of the antigen might be the trigger for the development of the autoimmune response against P proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11114288      PMCID: PMC1753357          DOI: 10.1136/ard.60.1.72

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  12 in total

Review 1.  Autoantigens in systemic autoimmunity: critical partner in pathogenesis.

Authors:  A Rosen; L Casciola-Rosen
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

2.  Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins.

Authors:  M Mahler; K Kessenbrock; J Raats; R Williams; M J Fritzler; M Blüthner
Journal:  J Mol Med (Berl)       Date:  2003-03-14       Impact factor: 4.599

Review 3.  Autoantigenesis: the evolution of protein modifications in autoimmune disease.

Authors:  Hester A Doyle; Mark J Mamula
Journal:  Curr Opin Immunol       Date:  2011-12-29       Impact factor: 7.486

Review 4.  Targeting apoptosis in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2014-07-20       Impact factor: 3.199

5.  Identification of a hypothetical membrane protein interactor of ribosomal phosphoprotein P0.

Authors:  K Aruna; Tirtha Chakraborty; Savithri Nambeesan; Abdul Baru Mannan; Alfica Sehgal; Seema R Bhalchandara; Shobhona Sharma
Journal:  J Biosci       Date:  2004-03       Impact factor: 1.826

6.  Anti-alpha-fodrin antibodies do not add much to the diagnosis of Sjögren's syndrome.

Authors:  Michiel M Zandbelt; Judith Vogelzangs; Leo BA Van De Putte; Walther J Van Venrooij; Frank HJ Van Den Hoogen
Journal:  Arthritis Res Ther       Date:  2003-10-31       Impact factor: 5.156

Review 7.  Coherent somatic mutation in autoimmune disease.

Authors:  Kenneth Andrew Ross
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

8.  Expression, tissue localization and serodiagnostic potential of Taenia multiceps acidic ribosomal protein P2.

Authors:  Xing Huang; Lin Chen; Yingdong Yang; Xiaobin Gu; Yu Wang; Weimin Lai; Xuerong Peng; Guangyou Yang
Journal:  Parasit Vectors       Date:  2015-12-01       Impact factor: 3.876

9.  Physical exercise in aging human skeletal muscle increases mitochondrial calcium uniporter expression levels and affects mitochondria dynamics.

Authors:  Sandra Zampieri; Cristina Mammucari; Vanina Romanello; Laura Barberi; Laura Pietrangelo; Aurora Fusella; Simone Mosole; Gaia Gherardi; Christian Höfer; Stefan Löfler; Nejc Sarabon; Jan Cvecka; Matthias Krenn; Ugo Carraro; Helmut Kern; Feliciano Protasi; Antonio Musarò; Marco Sandri; Rosario Rizzuto
Journal:  Physiol Rep       Date:  2016-12

10.  Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin.

Authors:  Erik R Vossenaar; Normand Després; Elvy Lapointe; Annemarie van der Heijden; Maximillian Lora; Tatsuo Senshu; Walther J van Venrooij; Henri A Ménard
Journal:  Arthritis Res Ther       Date:  2004-02-05       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.